Despite the slightly warmer weather and longer periods of sunshine, we are still in the depths of cold and flu season, a ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

This is the season for a rise in RSV cases. We talk to a local doctor on how to treat and stop the spread. Click here to ...

New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations Inhalon’s RSV candidate ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) as part of FluCamp. Inhalon’s candidate IN-002 will be investigated ...

“The treatment paradigm for respiratory infections is ripe for disruptive innovation. Preventive immunizations are underutilized, especially in RSV, where vaccine usage is now expected to be one ...

New at-home RSV treatment represents a potential breakthrough in addressing the burden of respiratory diseases, especially in vulnerable pediatric and elderly populations Inhalon’s RSV candidate is ...